Because of their effects on male and female breasts, estrogen and progesterone can promote the growth of some breast cancers. Breast cancers sensitive to hormones are typically referred to as hormone ...
Triple-positive breast cancer involves tumors positive for estrogen, progesterone, and HER2 receptors, affecting treatment decisions and strategies. Diagnosis includes imaging and biopsy to confirm ...
Hormone therapies have played a major role in improving survival for patients with ER+ breast cancer [1]. By blocking or reducing estrogen’s impact, these treatments slow the cancer’s growth and help ...
Advancements in understanding tumor biology, identifying predictive biomarkers, and developing targeted therapies have ...
MedPage Today on MSN
No Increased Breast Cancer Risk With Menopausal Estrogen in BRCA Carriers
Kotsopoulos noted that BRCA carriers have a substantially increased lifetime risk of breast and ovarian cancer. Management of ...
Please provide your email address to receive an email when new articles are posted on . Decades of evidence support the benefits of HT for menopausal symptoms, improved cardiac health, prevention of ...
As estrogen levels decline during menopause, it's common to experience vaginal dryness. This uncomfortable menopausal side effect can cause the vaginal area to feel itchy or sore, and can lead to ...
According to recent Surveillance, Epidemiology, and End Results program data, approximately 316,950 women and 2800 men are expected to be diagnosed with breast cancer, making it the most common ...
Hormone replacement therapy (HRT) does not increase breast cancer risk in BRCA1/BRCA2 carriers, with estrogen-alone formulations showing a lower risk. The study used a matched-pair design to control ...
Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited mutations in the BRCA1 or BRCA2 genes, according to the results of a matched ...
The drug dexamethasone supplements cancer treatments to alleviate side effects of chemotherapy such as nausea or inflammation. Researchers at the University of Basel, Switzerland, have now discovered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results